Host responses and persistence of vector genome following intrabronchial administration of an E1-E3- adenovirus gene transfer vector to normal individuals

Molecular Therapy

Volumn 3, Issue 2, 2001, Pages 206-215

  Harvey, Ben Gary ^a   Hackett, Neil R ^a   Ely, Scott ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; NEUTRALIZING ANTIBODY; VIRUS DNA; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHITIS; BRONCHUS BIOPSY; CELLULAR IMMUNITY; CLINICAL OBSERVATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DOSE RESPONSE; DRUG MECHANISM; ESCHERICHIA COLI; GENE EXPRESSION; GENE TRANSFER; GENETIC CODE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; LUNG ALVEOLUS EPITHELIUM; LUNG FLUID; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; NORMAL HUMAN; NOSE MUCOSA; PREDICTION; RESPIRATORY EPITHELIUM; SEROTYPE; TRACHEOBRONCHIAL TOILET;

ADENOVIRIDAE; ANIMALIA; BRONCHUS; DNA VIRUSES; ESCHERICHIA COLI;

EID: 0034993037     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0244     Document Type: Article

References (61)

1. Human gene therapy
2. Transfer of genes to humans: Early lessons and obstacles to success
3. Adenovirus vectors for gene therapy
4. Adenoviruses
5. Adenoviridae: The viruses and their replication
6. Adenoviruses as gene-delivery vehicles
7. Ability of adenovirus vectors containing different CFTR transcriptional cassettes to correct ion transport defects in CF cells
8. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium
9. Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: Efficiency of adenovirus-mediated gene transfer in vitro
10. Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial
11. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
12. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus
13. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector
14. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis
15. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis
16. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis
17. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis
18. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA
19. Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR2
20. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung
21. Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses
22. Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung
23. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
24. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs
25. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice
26. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype
27. "Sero-switch" adenovirus-mediated in vivo gene transfer: Circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype
28. Role of early genes in pathogenesis of adenovirus pneumonia
29. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs
30. Lung gene therapy: In vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium
31. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Biological efficacy study
32. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2a, or E1/E4 deleted
33. Adenovirus-mediated persistent cystic fibrosis transmembrane conductance regulator expression in mouse airway epithelium
34. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis
35. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats
36. Lower airway inflammation in infants and young children with cystic fibrosis
37. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis
38. Inflammatory cytokines in cystic fibrosis lungs
39. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation
40. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis
41. Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral 5-fluorocytosine
42. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo
43. - adenovirus gene transfer vector
44. Coarse spray delivery to a localized region of the pulmonary airways for gene therapy
45. Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosis
46. Use of bronchoalveolar lavage and airway brushing to investigate the human lung
47. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121
48. Analysis of risk factors for local delivery of low and intermediate dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions
49. Safety of local delivery of low and intermediate dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions
50. The differentiation potential of tracheal basal cells
51. Regeneration of rat tracheal epithelium after mechanical injury. I. The relationship between mitotic activity and cellular differentiation
52. Differentiation of tracheal mucociliary epithelium in primary cell culture recapitulates normal fetal development and regeneration following injury in hamsters
53. Biology of airway epithelial cells
54. Wound repair of human surface respiratory epithelium
55. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase
56. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung
57. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products
58. In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: Efficacy, toxicity and safety
59. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a
60. Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: A preclinical toxicology study
61. Biological response of nonhuman primates to long-term repeated lung exposure Ad2/CFTR-2